RxDoctor Payments Data

Jessica Prather, APRN

Nurse Practitioner · Walnut, MSNPI 1538624580

Payments from drug & device makers

$1,037in general payments, 2019–2025

Across 43 payments — averaging $24.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$352
  • Boston Scientific$292
  • Medtronic$218
  • Stryker$116
  • Relievant Medsystems, Inc.$20
  • SPR Therapeutics, Inc$20
  • plus $20 from 1 others

What the payments were for

  • Food & beverage$1,037100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,037 in reported general payments places this provider in the 70th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$300,695
Medicare patients
572
Services billed
4,169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl75$64,449
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,988$55,149
Xtampza ErOxycodone Myristate78$51,636
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,134$36,023
Nucynta ErTapentadol Hcl23$22,209
Hysingla ErHydrocodone Bitartrate14$15,502
LinzessLinaclotide25$13,047
Oxycodone Hcl389$8,842
MovantikNaloxegol Oxalate12$8,705
Morphine Sulfate ErMorphine Sulfate232$8,054
Buprenorphine15$7,071
Fentanyl53$6,129
Gabapentin675$5,579
Naproxen82$3,260
Diclofenac Sodium135$3,114

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er$352$73,845101 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Walnut

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →